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Mentor: Jill Clayton-Smith
Program: Neurology Epilepsy and intellectual disability comorbidity is a common condition with great medical and psychological impact on a patient's life and their family members.
We sought to investigate the genotype and phenotype of patients with epilepsy and intellectual disability comorbidity who had negative karyotyping and microarrays results, to find any statistical correlations of positive findings with specific clinical features, and to calculate the diagnostic rates of targeted exome sequencing panel and whole exome sequencing.
In 80 patients with the comorbid condition, recruited by the Manchester Centre of Genomic Medicine, we analyzed the relevant clinical information, collected data from 76 patients who were tested by a targeted exome sequencing panel assembled to diagnose this condition, and gathered the data of 16 patients who subsequently went on to be tested by whole exome sequencing.
The overall detection rate of pathogenic and likely pathogenic variants in genes associated with epilepsy and intellectual disability comorbidity was 24%. There was a 17% detection rate by the targeted exome sequencing panel (13/76), and 33% by whole exome sequencing (5/15). There was no significant statistical correlation identified between genotype and phenotype variables. The STXBP1 gene was the gene most frequently identified to carry a disease causing variant, seen in 5 patients.
This study demonstrated the considerable utility of the use of targeted exome sequencing as well as whole exome sequencing in this condition for detection of causative genetic variants. The absence of statistical correlation between the chances of finding a pathogenic result and a specific phenotype, suggests that the clinical presentations within this group are not always distinctive or that the use of a much larger study group is needed to improve the statistical power.  https://doi.org/10.32873/unmc.dc.gmerj.1.1.020 
Correlation of the Multi-Biomarker Disease Activity Score with Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis
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Background: There are conflicting reports on the validity of the multi-biomarker disease activity (MBDA) score to assess rheumatoid arthritis (RA) disease activity. We performed a systematic review of the MBDA and metaanalysis of the correlation between the MBDA and other RA disease activity measures.
Methods: A systematic review was performed, searching MEDLINE, EMBASE, Scopus, Google Scholar, and the Cochrane Library from inception to March 7, 2017. Study details, MBDA performance, and study quality were assessed by independent reviewers. Correlations of the MBDA with composite RA disease activity measures were pooled using random-effects meta-analyses.
Results:
Twenty-two studies were identified in the systematic review, of which 8 (n=3,242 assays) reported correlations of the MBDA with RA disease activity measures. Pooling results from these eight studies in the metaanalysis, the MBDA demonstrated modest correlations with DAS28-CRP (r = 0.41, 95% CI 0.36-0.46) and DAS28-ESR (r = 0.48, 95% CI 0.38-0.58) with weaker correlations observed with SDAI (r = 0.35, 95% CI 0.26-0.43), CDAI (r = 0.26, 95% CI 0.19-0.33), and RAPID3 (r = 0.23, 95% CI 0.19-0.27). Correlations between change in MBDA and change in disease activity measures ranged from r = 0.53 (DAS28-ESR) to r = 0.26 (CDAI). 
Conclusion
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Hantavirus Cardiopulmonary Syndrome (HCPS) is a relatively uncommon zoonotic viral illness classically associated with the southwestern United States. It is important for clinicians to include HCPS on the differential for diffuse alveolar hemorrhage (DAH) and acute respiratory distress syndrome (ARDS), as HCPS carries a high mortality rate and commonly goes unrecognized.
A middle-aged patient presented with fever and cough and was found to be hypotensive and thrombocytopenia. Despite being started on broad spectrum antibiotics, the patient's respiratory status rapidly declined, requiring intubation and ICU level of care. Chest radiographs revealed diffuse pulmonary
